Higher radiation doses tested for elderly brain cancer patients
NCT ID NCT06835803
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 40 times
Summary
This study tests whether a higher daily dose of radiation over three weeks can improve survival for people aged 65 and older with newly diagnosed glioblastoma, an aggressive brain cancer. Participants will be randomly assigned to receive either the standard radiation dose or an escalated dose. The trial aims to find a better balance between effectiveness and quality of life in this older population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dana-Farber Brigham Cancer Center, Milford Hospital
RECRUITINGMilford, Massachusetts, 01757, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dana-Farber Brigham Cancer Center, South Shore Hospital
RECRUITINGSouth Weymouth, Massachusetts, 02190, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy
What this could lead to
If it works, this could offer a more effective radiation schedule for older glioblastoma patients, potentially extending survival without lengthening treatment time.
What could go wrong
This is a small, early-phase trial with only 56 participants. Higher radiation doses may increase side effects, and the benefit over standard care is not yet proven.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.